Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2009

01-04-2009 | Research Article

Drug-related problems identified in medication reviews by Australian pharmacists

Authors: Andrew C. Stafford, Peter C. Tenni, Gregory M. Peterson, Shane L. Jackson, Anne Hejlesen, Christine Villesen, Mette Rasmussen

Published in: International Journal of Clinical Pharmacy | Issue 2/2009

Login to get access

Abstract

Objective In Australia, accredited pharmacists perform medication reviews for patients to identify and resolve drug-related problems. We analysed the drug-related problems identified in reviews for both home-dwelling and residential care-facility patients. The objective of this study was to examine the number and nature of the drug-related problems identified and investigate differences between each type of review. Setting Australian patients living at home or in residential care-facilities. Method We collected a nation-wide sample of medication reviews conducted between 1998 and 2005. These reviews had been self-selected by pharmacists and submitted as part of the reaccreditation process to the primary body responsible for accrediting Australian pharmacists to perform medication reviews. The drug-related problems identified in each review were classified by type and drugs involved. Main outcome measure The number and nature of drug-related problems identified in pharmacist-conducted medication reviews. Results There were 1,038 drug-related problems identified in 234 medication reviews (mean 4.6 (±2.2) problems per review). The number of problems was higher (4.9 ± 2.0 vs. 3.9 ± 2.2; < 0.001) in reviews for home-dwelling patients compared with care-facility residents. The number of clinically-significant problems was higher (2.1 ± 1.1 vs. 1.5 ± 0.7; P < 0.001) for home-dwelling patients. Oral hypoglycaemics and analgesics/antipyretics were significantly more likely to be associated with problems in home-dwelling patients than in residential care-facility patients. Conclusion These data illustrate the prevalence of drug-related problems and the ability of pharmacists to identify these problems in the Australian models of medication review. The nature and frequency of problems varied between reviews for home-dwelling and care-facility patients. Such information may be used to better focus the training of practitioners based on the most frequently encountered health problems and the nature of common drug-related problems in the two settings.
Literature
2.
go back to reference Farris KB, Ganther-Urmie JM, Fang G, Doucette WR, Brooks JM, Klepser DG, et al. Population-based medication reviews: a descriptive analysis of the medication issues identified in a Medicare not-for-profit prescription discount program. Ann Pharmacother. 2004;38(11):1823–9. doi:10.1345/aph.1E204.PubMedCrossRef Farris KB, Ganther-Urmie JM, Fang G, Doucette WR, Brooks JM, Klepser DG, et al. Population-based medication reviews: a descriptive analysis of the medication issues identified in a Medicare not-for-profit prescription discount program. Ann Pharmacother. 2004;38(11):1823–9. doi:10.​1345/​aph.​1E204.PubMedCrossRef
6.
13.
go back to reference Burkiewicz JS, Sweeney BL. Medication reviews in senior community housing centers. Consul Pharm. 2006;21(9):715–8. Burkiewicz JS, Sweeney BL. Medication reviews in senior community housing centers. Consul Pharm. 2006;21(9):715–8.
14.
15.
go back to reference Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12(3):176–80. doi:10.1136/qhc.12.3.176.PubMedCrossRef Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12(3):176–80. doi:10.​1136/​qhc.​12.​3.​176.PubMedCrossRef
17.
go back to reference Peterson GM, Tenni PC. Identifying, prioritising and documenting drug-related problems. Aust Pharm. 2004;23(10):706–9. Peterson GM, Tenni PC. Identifying, prioritising and documenting drug-related problems. Aust Pharm. 2004;23(10):706–9.
19.
22.
go back to reference Elliott RA. Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res. 2006;36(1):58–66. Elliott RA. Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res. 2006;36(1):58–66.
23.
go back to reference Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalisations and emergency department visits due to drug–drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007;16(6):641–51. doi:10.1002/pds.1351.PubMedCrossRef Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalisations and emergency department visits due to drug–drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007;16(6):641–51. doi:10.​1002/​pds.​1351.PubMedCrossRef
Metadata
Title
Drug-related problems identified in medication reviews by Australian pharmacists
Authors
Andrew C. Stafford
Peter C. Tenni
Gregory M. Peterson
Shane L. Jackson
Anne Hejlesen
Christine Villesen
Mette Rasmussen
Publication date
01-04-2009
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 2/2009
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-009-9287-y

Other articles of this Issue 2/2009

International Journal of Clinical Pharmacy 2/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.